Clinical Trials on McCune-Albright Syndrome in New Zealand

Total 4000 results

Yale University

Withdrawn

Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome

Diabetes Mellitus | Fibrous Dysplasia | McCune-Albright Syndrome | Intraductal Papillary Mucinous Neoplasm

United States
AstraZeneca

Completed

Faslodex in McCune-Albright Syndrome (FMAS)

Puberty, Precocious | McCune-Albright Syndrome

Italy, United States, Germany, France, Russian Federation, United Kingdom
PAVmed Inc.

Completed

PAVmed CarpX Device Clinical Study

Carpal Tunnel Syndrome

New Zealand
Fisher and Paykel Healthcare

Terminated

Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)

Obesity Hypoventilation Syndrome

New Zealand
Fisher and Paykel Healthcare

Terminated

Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome

New Zealand
University of Auckland, New Zealand
Auckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...

Completed

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene (PCOSMIC)

Polycystic Ovary Syndrome

New Zealand
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
Zhejiang Doer Biologics Co., Ltd.

Recruiting

A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624

Healthy, Obesity, Metabolically

New Zealand
Fisher and Paykel Healthcare

Completed

Novel Auto-continuous Positive Airway Pressure (CPAP) Validation

Sleep Apnea, Obstructive

New Zealand
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Fisher and Paykel Healthcare

Completed

Investigative Headgear With CPAP Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Investigative Headgear With Nasal Pillows Continuous Positive Airway Pressure (CPAP) Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

CPAP In-home Assessment NZ

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Comparison of Breathing Events Detected by the SleepStyle 200 Auto Continuous Positive Airway Pressure (CPAP) Device to Attended Polysomnography

Sleep Apnea, Obstructive

New Zealand
Fisher and Paykel Healthcare

Completed

CPAP Device In-lab Assessment NZ

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Validation of HC250 and HC240 Series.

Obstructive Sleep Apnea (OSA)

New Zealand
Fisher and Paykel Healthcare

Completed

An Investigation to Test a Prototype Nasal Mask in the Home Setting

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Terminated

Physiological Study to Compare Noninvasive Ventilation (NIV) Masks

Sleep-disordered Breathing | Hypercapnia

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.

Obstructive Sleep Apnea (OSA)

New Zealand
Fisher and Paykel Healthcare

Completed

Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea in New Zealand

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Terminated

Evaluation of Treatment Efficacy of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Novel Nasal Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

An Investigation to Test a Prototype Full-face Mask in the Home Setting

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Terminated

Humidification Needs

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Evaluation of a Full Face Mask and Headgear for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
Australian and New Zealand Intensive Care Research...
Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaborators

Completed

The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial (VITAMINS)

Sepsis | Shock, Septic | Critically Ill | Vasoplegic Syndrome

Australia, New Zealand, Brazil
Otsuka Australia Pharmaceutical Pty Ltd

Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia (PREFER-HMA)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient Preference

New Zealand, Australia
Fisher and Paykel Healthcare

Terminated

Nasal High Flow Therapy for the Treatment of Respiratory Insufficiencies During Sleep

Sleep Disordered Breathing | Congestive Heart Failure

New Zealand
Fisher and Paykel Healthcare

Completed

F&P Toffee Full Face Mask Clinical Trial, NZ, 2020

Obstructive Sleep Apnea | Positive Airway Pressure Therapy

New Zealand
ImmusanT, Inc.

Completed

Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

Celiac Disease

New Zealand, Australia
Fisher and Paykel Healthcare

Completed

The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
James Cook University, Queensland, Australia
National Health and Medical Research Council, Australia; The Prince Charles... and other collaborators

Completed

Hookworm Therapy for Coeliac Disease (NainCeD-3)

Celiac Disease

Australia, New Zealand
Hvidovre University Hospital
Physical Medicine and Rehabilitation Research - Copenhagen (PMR-C).; School... and other collaborators

Unknown

Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).

Subacromial Impingement Syndrome | Central Nervous System Sensitization

Denmark
National Cancer Institute (NCI)

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditions

United States, Canada, New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of an Alternative Sizing Model in Comparison of a Conventional Sizing Model for Full Face Masks in the Treatment of OSA in Terms of Performance and Comfort

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Rigel Pharmaceuticals

Recruiting

Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria

New Zealand, Korea, Republic of, Italy
Rockefeller University

Completed

Immunotherapy of the Paraneoplastic Syndromes

Paraneoplastic Syndromes

United States
University of British Columbia

Completed

Predicting Complications in Women With Toxaemia

Toxemia

United Kingdom, Canada, New Zealand
Intellia Therapeutics

Not yet recruiting

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Hereditary Angioedema

France, New Zealand, United Kingdom
Apellis Pharmaceuticals, Inc.

Completed

Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects. (PADDOCK)

Paroxysmal Nocturnal Hemoglobinuria

Hong Kong, Thailand, New Zealand, Malaysia
Onconova Therapeutics, Inc.

Completed

Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs

Myelodysplastic Syndromes

United States, France, Germany

Clinical Trials on McCune-Albright Syndrome in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations